24 results
DEFR14A
RNLX
Renalytix Plc
13 Nov 23
Revised proxy
5:15pm
Innovation Partners, and the executive vice president and chief commercial innovation officer of the Mount Sinai Health System. In addition to his service … (“UCSF”), including as the Assistant Vice Chancellor of Innovation, Technology & Alliances, Assistant Vice Chancellor of Research and principal
DEF 14A
RNLX
Renalytix Plc
13 Nov 23
Definitive proxy
9:22am
in various roles at Mount Sinai, where he is currently the president of Mount Sinai Innovation Partners, and the executive vice president and chief … commercial innovation officer of the Mount Sinai Health System. In addition to his service on the Board, Dr. Lium represents Mount Sinai on several
PRE 14A
RNLX
Renalytix Plc
3 Nov 23
Preliminary proxy
4:04pm
2018. Since March 2014, Dr. Lium has served in various roles at Mount Sinai, where he is currently the president of Mount Sinai Innovation Partners … , and the executive vice president and chief commercial innovation officer of the Mount Sinai Health System. In addition to his service on the Board, Dr
10-K/A
2023 FY
RNLX
Renalytix Plc
5 Oct 23
Annual report (amended)
8:30pm
at Mount Sinai, where he is currently the president of Mount Sinai Innovation Partners, and the executive vice president and chief commercial … innovation officer of the Mount Sinai Health System. In addition to his service on the board Dr. Lium represents Mount Sinai on several private company boards
10-K
2023 FY
RNLX
Renalytix Plc
28 Sep 23
Annual report
6:18am
with healthcare systems;
confidence in diagnostic or prognostic performance;
technical performance and innovation to deliver products that provide … also rely on trademark registration, trade secrets, know how, other proprietary information and continuing technological innovation to develop
10-K
EX-10.9
f37zb
28 Sep 23
Annual report
6:18am
6-K
6m7xn5ccpkbimo8mwc
9 Jun 23
Current report (foreign)
7:01am
6-K
vdswe169 4t3ti3u
30 Mar 23
Current report (foreign)
7:01am
6-K
EX-99.1
j5iq4 qck
22 Nov 22
Annual Report and For the Year Ended 30 June 2022
5:09pm
6-K
EX-99.3
86lgkmh7zpybey0
22 Nov 22
Annual Report and For the Year Ended 30 June 2022
5:09pm
6-K
EX-99.1
24p87 twt6
30 Nov 21
Renalytix plc Annual Report and Financial Statements FOR THE YEAR ENDED 30 JUNE 2021
4:15pm
6-K
EX-99.1
olxq8c6bsj3sf3xju44x
30 Aug 21
Renalytix Appoints Daniel J. Levangie to its Board of Directors
4:05pm
6-K
EX-99.1
eox0kw0u kg3t
2 Mar 21
RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021
6:10am
20-F
099mym7q7ao
28 Oct 20
Annual report (foreign)
12:00am
6-K
EX-99.1
ty0prfi
27 Oct 20
Current report (foreign)
6:39am
424B4
kvzhmtv
17 Jul 20
Prospectus supplement with pricing info
5:15pm
F-1/A
l33jqt30yvmx610
13 Jul 20
Registration statement (foreign) (amended)
6:59am
F-1
07bxo6cx 3wylj
24 Jun 20
Registration statement (foreign)
5:07pm